- 1-800-Flowers.Com Inc (NASDAQ:FLWS) reported a fourth-quarter FY22 sales decline of 0.22% year-on-year to $485.89 million, marginally missing the consensus of $486.04 million.
- Revenues from Gourmet Foods and Gift Baskets fell 2.4% Y/Y, Consumer Floral & Gifts increased 0.4%, and BloomNet climbed 3.2%.
- Gross profit for the quarter declined 17.3% Y/Y, and the margin decreased 700 basis points to 33.7%.
- The operating loss for the quarter was $(27) million versus an income of $15.3 million last year.
- Adjusted EBITDA loss for the quarter was $(16.8) million versus an adjusted EBITDA of $30.2 million last year.
- Adjusted EPS loss of $(0.34) missed the analyst consensus of $(0.26).
- 1-800-Flowers.Com held $31.5 million in cash and equivalents as of July 3, 2022. Inventories as of July 3, 2022, increased 60.8% Y/Y to $247.6 million.
- For FY22, total net revenues increased 4% to $2.21 billion, with EPS of $0.45 and adjusted EPS of $0.50.
- “The unprecedented, rapid rise in costs impacted our gross margins and operating expenses – including labor, shipping, commodities, and digital marketing,” said CEO Chris McCann.
- Outlook: 1-800-Flowers.Com anticipates Q1 revenues to be down 3.0%-6.0% Y/Y. It sees an adjusted EBITDA loss of $(28.0) million-$(33.0) million.
- Price Action: FLWS shares are trading lower by 7.72% at $8.01 in premarket on the last check Thursday.
ZyVersa Therapeutics Announces Article Published In Metabolism Pointing To Glomerular Cholesterol Accumulation As Key Factor Exacerbating Renal Injury And Dysfunction In Diabetic Kidney Disease
Published data demonstrate that a deficiency in cholesterol transporter ABCA1 increases deposition of cellular cholesterol, contributing to inflammation, cell death (apoptosis), and damage to the kidney's
